Vincenzo

Biography

Prof. Vincenzo Cerundolo works in the Weatherall Institute of Molecular Medicine, Oxford. He graduated in Medicine at the University of Padua, Italy where he completed his Ph.D. in Immunology, and subsequently moved to the UK as an EMBO Fellow to work with Professor Alain Townsend on antigen presentation. In 1990, he described the first human antigen processing deficient cells, which led to the cloning and characterization of TAP1 and TAP2 genes. He was appointed Professor of Immunology at the University of Oxford in 2000 and became Director of the MRC Human Immunology Unit in 2010. In 2012, he was appointed Head of the Investigative Medicine Division of the newly-formed Radcliffe Department of Medicine of the University of Oxford. He is a Fellow of Merton College, of the Royal College of Pathologists, Batsheva Fellow of the Israeli Academy of Medical Sciences, and a Fellow of the Academy of Medical Sciences, UK. Prof. Cerundolo sits on the Scientific Advisory Board of numerous keynote institutions and charitable organisations, and serves on the Editorial boards of several leading peer-reviewed journals in the field. Research carried out in Professor Cerundolo’s laboratory is mainly focused on gaining a better understanding of the mechanisms that control the cell-cell interplay required for optimal expansion and activation of tumour-specific T cell populations and to apply this knowledge to the development of better treatment strategies in cancer patients.

Research Interest

Medicine